PRDM1 and hepatocellular carcinoma: Here, we found that PRDM1-overexpressing HCC cells upregulated PD-L1 expression and inhibited T cell-mediated anti-tumor immunity, thus dampening its role as a tumor growth suppressor in immunocompetent mice.